Korea FilingsFull brief — $39

Boryung Corporation

(주)보령 · KOSPI: 003850 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
(주)보령
Market / ticker
KOSPI · 003850
Industry
Pharmaceuticals and medicinal chemicals
Established
1963-11-11
Fiscal year ends
December
Website
www.boryung.co.kr
DART corp code
00123143
Latest revenue
₩1.02T (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩859.6B₩1.02T₩1.02T
Operating income₩68.3B₩70.5B₩65.1B
Net income₩40.2B₩69.6B₩64.3B
Total assets₩915.5B₩1.16T₩1.39T
Total liabilities₩366.3B₩379.6B₩542.4B
Total equity₩549.3B₩784.5B₩845.5B
Share capital₩34.3B₩43.4B₩43.4B

Consolidated statements · FY2025 operating margin 6.4% · liabilities to equity 64% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 62 (current)한영회계법인Unqualified
Term 61 (prior)삼정회계법인Unqualified
Term 60 (two years prior)삼정회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-15Amended: Treasury share disposal results reportDART
2026-09-15Amended: Material event report — Treasury share disposal decisionDART
2026-09-15Record date / shareholder register closure setDART
2026-09-15Resolution to convene shareholders meetingDART
2026-09-15Material event reportDART
2026-09-11Treasury share acquisition results reportDART
2026-08-26Fair trade compliance program status (notice)DART
2026-08-19Investor relations event (notice)DART
2026-08-14Half-year report (2026.06)DART
2026-08-06Preliminary consolidated operating results (fair disclosure)DART
2026-07-09Amended: Annual report (2025.12)DART
2026-06-22Large shareholding (5%+) reportDART
2026-06-12Material event report — Treasury share acquisition decisionDART
2026-06-10Large shareholding (5%+) reportDART
2026-06-01Sustainability report (voluntary)DART
2026-06-01Amended: Material management matterDART
2026-05-29Corporate governance reportDART
2026-05-14Quarterly report (2026.03)DART
2026-05-06Officer / major shareholder ownership reportDART
2026-05-06Officer / major shareholder ownership reportDART

Showing the 20 most recent of 45 filings. The full brief lists all of them.

Full brief on Boryung Corporation — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.